Risk of delays in OBIC7 development and higher development costs
First written in FY2016. 28 of 30 entries say "Restated". Latest entry: FY2025.
3 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「However, technological innovation is advancing rapidly across a broad range of fields, and we believe that if our response is delayed, our business performance could be affected by lost opportunities resulting from delays in product development and higher development costs.」
The company continues to identify the risks of product development delays, lost opportunities and higher development costs arising from delays in responding to technological innovation. - FY2024-Q3RestatedAnnual report
「No new business or other risks arose during the first nine months of the current consolidated fiscal year. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of OBIC7 development delays and higher development costs are treated as having had no new occurrences or significant changes. - FY2024-Q2RestatedAnnual report
「No new business or other risks arose during the first half of the current consolidated fiscal year. In addition, no material changes have occurred in the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2024-Q1RestatedAnnual report
「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2023-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended [the current third quarter]. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risks of OBIC7 development delays and higher development costs are treated as having had no new occurrences or significant changes. - FY2022RestatedAnnual report
「However, technological innovation is advancing rapidly across a broad range of fields, and we believe that if our response is delayed, our business performance could be affected by lost opportunities resulting from delays in product development and higher development costs.」
The company continues to identify the risks of product development delays, lost opportunities and higher development costs arising from delays in responding to broad-based technological innovation. - FY2022-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended 31 December. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2022-Q2RestatedAnnual report
「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The risks of OBIC7 development delays and higher development costs are treated as having had no new occurrences or significant changes. - FY2022-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2021ReframedAnnual report
「However, technological innovation is advancing rapidly across a broad range of fields, and we believe that if our response is delayed, our business performance could be affected by lost opportunities resulting from delays in product development and higher development costs.」
The risk assessment has expanded from the conventional risks of OBIC7 development delays and higher costs to include lost opportunities arising from delays in responding to broad-based technological innovation. - FY2021-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended [the current third quarter]. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2021-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2020-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended [the current third quarter]. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2020-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2020-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2019RestatedAnnual report
「Our core product, the integrated business software “ＯＢＩＣ７ Series,” currently accounts for more than half of total revenue. The development timing and product development methods for this core system and its peripheral submodule suite are significantly affected by the evolution and changes in the platforms and programming languages that support them. We believe there is a risk that delays in product launch schedules and higher development costs could affect our business performance.」
Against a backdrop of OBIC7 accounting for more than half of total revenue, the company continues to identify the risks of development delays and higher costs. - FY2019-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended [the current third quarter]. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2019-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2019-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2018RestatedAnnual report
「Our core product, the integrated business software “ＯＢＩＣ７ Series,” currently accounts for more than half of total revenue. The development timing and product development methods for this core system and its peripheral submodule suite are significantly affected by the evolution and changes in the platforms and programming languages that support them. We believe there is a risk that delays in product launch schedules and higher development costs could affect our business performance.」
Against a backdrop of OBIC7 accounting for more than half of total revenue, the company continues to identify risks of development delays and higher costs arising from changes in platforms and programming languages. - FY2018-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended [the current third quarter]. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The risks of OBIC7 development delays and higher development costs are treated as having had no new occurrences or significant changes. - FY2018-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2018-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2017RestatedAnnual report
「Our core product, the integrated business software “ＯＢＩＣ７ Series,” currently accounts for more than half of total revenue. The development timing and product development methods for this core system and its peripheral submodule suite are significantly affected by the evolution and changes in the platforms and programming languages that support them. We believe there is a risk that delays in product launch schedules and higher development costs could affect our business performance.」
Against a backdrop of OBIC7 accounting for more than half of total revenue, the company continues to identify risks of development delays and higher costs arising from changes in platforms and programming languages. - FY2017-Q3RestatedAnnual report
「No new business or other risks arose during the nine months ended [the current third quarter]. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new occurrences or significant changes concerning the risks of OBIC7 development delays and higher development costs. - FY2017-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The risks of OBIC7 development delays and higher development costs are treated as having undergone no significant changes. - FY2017-Q1RestatedAnnual report
「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new risks or significant changes concerning overall business and other risks, and that the risks of OBIC7 development delays and higher development costs remain unchanged. - FY2016First statedAnnual report
「Our core product, the integrated business software “ＯＢＩＣ７ Series,” currently accounts for more than half of total revenue. The development timing and product development methods for this core package and its peripheral submodule suite are significantly affected by the evolution and changes in the platforms and programming languages that support them. We believe there is a risk that delays in product launch schedules and higher development costs could affect our business performance.」
Against a backdrop of the core product accounting for more than half of total revenue, delays in development and rising costs arising from changes in platforms and programming languages are identified as risks. No current manifestation of these risks is stated.